IMB-808 is an LXRalpha/beta dual agonist that promotes ABCA1 expression and cholesterol efflux without inducing lipidogenesis in HepG2 cells. IMB-808 can be used in atherosclerosis research.
Molecular Weight:
380.32
Purity:
99.93%
CAS Number:
[870768-70-0]
Formula:
C18H15F3N2O4
Target:
Antibacterial|||Liver X Receptor
T25528
T25528
* VAT and and shipping costs not included. Errors and price changes excepted
